×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Schroeder Theodore R

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NBRVNabriva Therapeutics plcSchroeder Theodore RDirectorJan 29, 2023Option Exercise$1.5043164711,989Jan 31, 2023, 08:55 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 06, 2023Option Exercise$1.30111412,420Jan 10, 2023, 05:56 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 31, 2022Option Exercise$1.895912,431Jan 04, 2023, 06:09 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 06, 2022Option Exercise$2.0291812,436Dec 08, 2022, 04:34 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 30, 2022Option Exercise$2.2551112,445Dec 02, 2022, 05:15 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 06, 2022Option Exercise$2.24102212,450Nov 08, 2022, 05:24 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 31, 2022Option Exercise$2.5451312,460Nov 01, 2022, 05:08 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 06, 2022Option Exercise$2.7292412,465Oct 11, 2022, 05:03 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 30, 2022Option Exercise$2.0851012,474Oct 04, 2022, 09:31 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 06, 2022Option Exercise$0.1622535311,977Sep 07, 2022, 06:00 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 31, 2022Option Exercise$0.1610718312,202Sep 01, 2022, 06:38 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 06, 2022Option Exercise$0.1822542312,309Aug 08, 2022, 05:44 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 31, 2022Option Exercise$0.1810719312,534Aug 03, 2022, 09:45 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 06, 2022Option Exercise$0.1822541312,641Jul 07, 2022, 04:11 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 30, 2022Option Exercise$0.1810719312,866Jul 01, 2022, 06:08 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 06, 2022Option Exercise$0.2022545312,973Jun 07, 2022, 04:47 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 31, 2022Option Exercise$0.2110722313,198Jun 02, 2022, 04:10 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 06, 2022Option Exercise$0.2622558313,305May 09, 2022, 06:32 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 30, 2022Option Exercise$0.3110733313,530May 03, 2022, 04:59 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 06, 2022Option Exercise$0.4121990313,637Apr 08, 2022, 04:16 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 31, 2022Option Exercise$0.4210444313,856Apr 04, 2022, 06:27 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 06, 2022Option Exercise$0.43263113313,960Mar 08, 2022, 04:12 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 28, 2022Option Exercise$0.4512556314,223Mar 02, 2022, 07:51 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 06, 2022Option Exercise$0.48263126314,348Feb 08, 2022, 04:25 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 29, 2022Option Exercise$0.4510,7664,845314,736Feb 01, 2022, 08:47 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 31, 2022Option Exercise$0.4812560314,611Feb 01, 2022, 08:47 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 06, 2022Option Exercise$0.58270157325,502Jan 10, 2022, 04:19 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 28, 2021Buy$0.57100,00057,320325,879Dec 29, 2021, 09:32 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 06, 2021Option Exercise$0.72225162225,879Dec 08, 2021, 05:14 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 30, 2021Option Exercise$0.7810783226,104Dec 02, 2021, 06:31 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 06, 2021Option Exercise$1.33225299226,211Nov 09, 2021, 05:38 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 31, 2021Option Exercise$1.15107123226,436Nov 01, 2021, 07:51 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 06, 2021Option Exercise$1.08225243226,543Oct 08, 2021, 04:39 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 30, 2021Option Exercise$1.19107127226,768Oct 04, 2021, 04:14 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 14, 2021Buy$1.1350,00056,500226,875Sep 15, 2021, 08:00 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 06, 2021Option Exercise$1.11225250176,875Sep 08, 2021, 05:27 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 31, 2021Option Exercise$1.06107113177,100Sep 02, 2021, 04:07 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 06, 2021Option Exercise$1.17225263177,207Aug 10, 2021, 05:16 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 31, 2021Option Exercise$1.10107118177,432Aug 03, 2021, 04:09 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 06, 2021Option Exercise$1.27225286177,539Jul 08, 2021, 04:11 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 30, 2021Option Exercise$1.35107144177,764Jul 02, 2021, 04:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 06, 2021Option Exercise$1.49225335178,203May 10, 2021, 05:53 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 30, 2021Option Exercise$1.78107190178,428May 04, 2021, 04:03 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 06, 2021Option Exercise$2.902,6957,816178,985Apr 08, 2021, 09:48 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 06, 2021Option Exercise$1.79225403178,760Apr 08, 2021, 09:48 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 06, 2021Option Exercise$1.73225389178,535Apr 08, 2021, 09:48 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 28, 2021Option Exercise$2.39106253181,787Mar 02, 2021, 07:42 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 31, 2021Option Exercise$2.62125327181,893Feb 02, 2021, 08:01 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerDec 31, 2020Option Exercise$2.4212129364,518Jan 05, 2021, 05:15 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerNov 30, 2020Option Exercise$0.431,211517646,396Dec 01, 2020, 08:21 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerOct 31, 2020Option Exercise$0.501,211600647,607Nov 02, 2020, 07:07 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerSep 30, 2020Option Exercise$0.531,211645648,818Oct 01, 2020, 04:32 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 31, 2020Option Exercise$0.621,211750650,029Sep 02, 2020, 05:15 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJul 31, 2020Option Exercise$0.761,211920651,240Aug 04, 2020, 04:08 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJun 30, 2020Option Exercise$0.671,211817652,451Jul 02, 2020, 04:06 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMay 31, 2020Option Exercise$1.141,2111,381653,662Jun 03, 2020, 06:07 AM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerApr 30, 2020Option Exercise$0.551,211664648,686May 04, 2020, 06:31 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerMar 31, 2020Option Exercise$0.571,211696649,897Apr 02, 2020, 05:48 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerFeb 28, 2020Option Exercise$1.351,2111,635651,108Mar 03, 2020, 09:32 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerJan 31, 2020Option Exercise$1.3516,27621,973302,760Feb 04, 2020, 08:55 PM
NBRVNabriva Therapeutics plcSchroeder Theodore RChief Executive OfficerAug 27, 2019Buy$1.7950,00089,500117,489Aug 28, 2019, 04:01 PM
HPTXHYPERION THERAPEUTICS INCSchroeder Theodore RDirectorMay 07, 2015Option Exercise$46.003,700170,2000May 08, 2015, 07:58 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEOMar 19, 2014Option Exercise$14.0012,664177,2960Mar 21, 2014, 01:28 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEOMar 19, 2014Option Exercise$14.00307,5004,305,0000Mar 21, 2014, 01:28 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEONov 02, 2011Option Exercise$5.727,33641,96212,664Nov 04, 2011, 04:45 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEOMay 17, 2011Buy$7.4816,000119,626307,500May 17, 2011, 06:18 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEOSep 30, 2010Sale$8.3540,703339,691320,297Oct 04, 2010, 04:16 PM
CADXCADENCE PHARMACEUTICALS INCSchroeder Theodore RPresident, CEOOct 01, 2010Sale$8.359,29777,670311,000Oct 04, 2010, 04:16 PM